行情

ASMB

ASMB

Assembly生物
NASDAQ

实时行情|Nasdaq Last Sale

16.43
+0.43
+2.69%
盘后: 16.32 -0.11 -0.69% 16:11 12/06 EST
开盘
16.11
昨收
16.00
最高
16.77
最低
15.80
成交量
30.97万
成交额
--
52周最高
25.68
52周最低
8.13
市值
4.28亿
市盈率(TTM)
-4.3661
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ASMB 新闻

  • Assembly Biosciences Announces Plenary Lecture at HEP DART 2019
  • GlobeNewswire.11小时前
  • Assessing Assembly Biosciences
  • Seeking Alpha - Article.3天前
  • 消息人士:日本政府正在制定1200亿美元刺激方案
  • 环球外汇网官网.3天前
  • 意大利再次修正2020财政预算案 推多项惠民政策
  • 中国新闻网.3天前

更多

所属板块

制药
+0.11%
制药与医学研究
+0.32%

热门股票

名称
价格
涨跌幅

ASMB 简况

Assembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. It has discovered various core protein Allosteric Modulators (CpAMs), which are small molecules that directly target and allosterically modulate the HBV core (HBc) protein. Its Microbiome Program consists of an integrated platform that includes a strain identification and selection process, methods for strain isolation and growth under current good manufacturing practice conditions, and a delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal (GI) tract. The lead product candidate from this platform, AB-M101, is in development for the treatment of clostridium difficile-infections.
展开

Webull提供Assembly Biosciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。